9 results on '"Koutoulaki, Chara"'
Search Results
2. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.
- Author
-
Michaelidou, Kleita, Karniadakis, Ioannis, Pantelaion, Varvara, Koutoulaki, Chara, Boukla, Eleni, Folinas, Konstantinos, Dimaras, Pantelis, Papadaki, Maria A, Koutsopoulos, Anastasios V, Mavroudis, Dimitrios, Vourlakou, Christine, Mavridis, Konstantinos, and Agelaki, Sofia
- Abstract
Limited information exists on epidermal growth factor receptor (EGFR) molecular epidemiology in Greece. Next-generation sequencing (NGS) is the recommended method for EGFR genotyping in NSCLC. The Idylla Biocartis platform is a fully automated system for actionable EGFR mutation detection. We describe the prevalence of EGFR mutations in NSCLC patients in two high-volume clinical centers in Greece and compare key methods used for their determination. Eight hundred and fifty-seven FFPE samples from NSCLC patients were tested for EGFR mutations at University of Crete (UoC; n = 324) and at Evangelismos Hospital, Athens (Evangelismos; n = 503). The prevalence of EGFR mutations was 11.1% in the whole cohort (11.5% in non-squamous). The detection rate was 11.0% by NGS, 9.8% by Sanger and 11.3% by Idylla for the whole cohort (12.0% in non-squamous). The agreement between Idylla and Sanger was 93.2%. A targetable EGFR mutation was detected in 10.0% using tissue NGS alone, and in 16.0% using concurrent Idylla ctEGFR testing. The frequency of EGFR mutations was as expected for a Caucasian population. The Idylla EGFR test performance is comparable to reference methods and with a shorter TAT. Adding a concurrent plasma Idylla test to tissue NGS testing increases the detection rate of EGFR mutations in NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations.
- Author
-
Sfakianaki, Maria, Tzardi, Maria, Tsantaki, Konstantina, Koutoulaki, Chara, Messaritakis, Ippokratis, Datseri, Galateia, Moustou, Eleni, Mavroudis, Dimitrios, and Souglakos, John
- Subjects
METABOLIC disorder diagnosis ,STATISTICS ,GENETIC mutation ,MOLECULAR diagnosis ,IMMUNOHISTOCHEMISTRY ,GENETIC testing ,HEREDITARY nonpolyposis colorectal cancer ,GENE expression profiling ,DESCRIPTIVE statistics ,DNA-binding proteins ,SENSITIVITY & specificity (Statistics) ,TUMORS ,POLYMERASE chain reaction ,DNA repair ,EVALUATION - Abstract
Simple Summary: Mismatch repair (MMR) system deficiency results in increased mutation rates with consequent microsatellite instability (MSI) and susceptibility to carcinogenesis. Clinically, testing MSI status contributes not only to early Lynch syndrome detection, which is associated with an increased risk of various cancers, but also to predicting the biomarkers of response to immune checkpoint inhibitors. In addition, it works prognostically because patients with the MSI phenotype or deficient MMR system (MSI-H or dMMR) characteristics show improved overall survival compared to patients with microsatellite stability or a proficient MMR system (MSS or pMMR). Here, we compare the two methods for MSI testing and outline the pros and cons of both methodologies, as well as examine their sensitivity, complementation, and degree of concordance to clarify to clinicians the ultimate methodology for MSI testing for different cancer types. Both methods are generally known to produce false negative results under certain circumstances, even in technically ideal situations. It is recommended that both methods ought to be established for determining MSI-H and dMMR status, respectively, for all cancer types as a first-line screening test, regarding the substantial agreement of the two methods in the present study. MMR gene germline mutations are considered a major genetic disorder in patients with hereditary nonpolyposis colon cancer (HNPCC) or Lynch syndrome; A total of 15% of sporadic colon carcinomas are MSI-High. MSI has also been observed in other cancers, such as endometrial, gastric, and ovarian cancer. The aim of the current study was to correlate and outline the optimal method between the molecular testing of the instability of microsatellite DNA regions (MSI status) and the loss of protein expression by immunehistochemistry (MMR). A total of 242 paraffin-embedded tissues from gastrointestinal, gynecological, genitourinary, lung, breast, and unknown primary cancer patients were analyzed for the expression of MLH1/MSH2/MSH6/PMS2 by immunohistochemistry, as well as for the molecular analysis of MSI status using PCR-based molecular fragment analysis. A total of 29 MSI-High patients were detected molecularly, while 23 patients were detected by immunohistochemistry, with rates that are comparable according to the literature. Based on the agreement coefficient of the two methods, a substantial agreement emerged (Kappa = 0.675 with standard error = 0.081, p < 0.001). Despite the substantial agreement, both methods ought to be established to determine MSI-H/dMMR status in all cancer types as a first-line screening test. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Influence of reaming intramedullary nailing on MSC population after surgical treatment of patients with long bone fracture.
- Author
-
Sperelakis, Ioannis, Tsitoura, Eliza, Koutoulaki, Chara, Mastrodimou, Semeli, Tosounidis, Theodoros H., Spandidos, Demetrios A., Antoniou, Katerina M., and Kontakis, George
- Subjects
INTRAMEDULLARY fracture fixation ,INTRAMEDULLARY rods ,BONE fractures ,MESENCHYMAL stem cells ,CHEMOKINE receptors ,CXCR4 receptors ,BONE marrow - Abstract
Reamed intramedullary nailing (RIN) is a surgical method of choice for treatment of diaphyseal fractures. This procedure affects the biological environment of bone tissue locally and systemically. This study investigated the influence of RIN on mesenchymal stem cells (MSCs) in patients with long bone fractures. The axis of C-X-C motif chemokine receptor 4 (CXCR4)/stromal cell-derived factor 1 (SDF-1) was selected since it is considered as major pathway for MSC homing and migration. Iliac crest bone marrow (IC-BM) samples and blood samples were collected at two different time points. One sample was collected before the RIN (BN) and the other immediately after RIN (AN). BM-MSCs were cultured and RT-qPCR was performed for CXCR4 mRNA levels and ELISA for the SDF-1 sera levels. The experimental study revealed that there was a correlation between the increase of SDF-1 levels in peripheral blood and a decrease in the levels of CXCR4 in MSCs in the IC-BM following RIN. The levels of SDF-1 showed a significant increase in the sera of patients after RIN. In conclusion, the present study is the first providing evidence of the effects of RIN on MSC population via the CXCR4/SDF-1 axis. The levels of serum SDF-1 factor were elevated after RIN while increased levels of SDF-1 in peripheral blood were inversely correlated with the mRNA levels of CXCR4 on BM-MSCs after RIN. Therefore, this study contributes to enlighten the systematic effects of RIN on the population of MSCs at a cellular level. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.
- Author
-
Bibaki, ElENi, Tsitoura, Eliza, Vasarmidi, Eirini, Margaritopoulos, George, Trachalaki, Athina, Koutoulaki, Chara, Georgopoulou, Theodora, Spandidos, Demetrios A., Tzanakis, Nikos, and Antoniou, Katerina M.
- Subjects
BRONCHOALVEOLAR lavage ,IDIOPATHIC pulmonary fibrosis ,LUNG cancer ,LUNG diseases ,MICRORNA - Abstract
Idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) constitute two progressively devastating lung diseases with common risk factors including aging and smoking. There is an increasing interest in the investigation of common pathogenic mechanisms between IPF and LC with therapeutic implications. Several oncomirs, microRNAs associated with malignancy, are also linked with IPF. miR‑29a and miR‑185 downregulation is probably involved both in carcinogenesis and fibrogenesis. We have previously observed miR‑29a and miR‑185 downregulation in IPF cells from bronchoalveolar lavage (BAL) and in this study we investigated their expression in LC BAL cells. Common targets of miR‑29a and miR‑185 such as DNA methyltransferase (DNMT)1, DNMT3b, COL1A1, AKT1 and AKT2 were measured. Potential correlations with pulmonary function tests, smoking status and endobronchial findings were investigated. Similar levels of miR‑29a and miR‑185 were detected in IPF and LC while their common targets AKT1 and DNMT3b were not found to differ, suggesting potential pathogenetic similarities at the level of key epigenetic regulators. By conrast, COL1A1 mRNA levels were increased in IPF suggesting a disease‑specific mRNA signature. Notably, DNMT1 was downregulated in the LC group and its expression was further reduced in the presence of increasing malignant burden as it was implied by the endobronchial findings. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients.
- Author
-
Messaritakis, Ippokratis, Sfakianaki, Maria, Vogiatzoglou, Konstantinos, Koulouridi, Asimina, Koutoulaki, Chara, Mavroudis, Dimitrios, Tzardi, Maria, Gouvas, Nikolaos, Tsiaoussis, John, and Souglakos, John
- Subjects
MICROSATELLITE repeats ,COLON cancer ,PROGNOSIS ,MULTIVARIATE analysis ,CAUSES of death - Abstract
Colorectal cancer (CRC) remains one of the leading causes of cancer-related death due to its high metastatic potential. This study aimed to investigate the detection and heterogeneity of circulating tumor cells (CTCs) and the microsatellite instability (MSI) status in advanced CRC patients prior to any systemic front-line treatment. Peripheral whole blood was obtained from 198 patients. CTCs were detected using double immunofluorescence and a real time-polymerase chain reaction assay; whereas MSI status was evaluated using fragment analysis. Median age of the patients was 66 years, 63.1% were males, 65.2% had a colon/sigmoid tumor location and 90.4% had a good performance status (PS). MSI-High status was detected in 4.9% of the patients; 33.3%, 56.1% and 8.6% patients had at least one detectable CEACAM5
+ /EpCAM+ , CEACAM5+ /EpCAM− and CEACAM5− /EpCAM+ CTC, respectively, and 9.1% of the patients had CEACAM5mRNA-positive CTCs. Following multivariate analysis, age, PS and MSI were confirmed as independent prognostic factors for decreased time to progression, whereas age, PS and CTC presence were confirmed as independent prognostic factors for decreased overall survival. In conclusion, our data support the use of CEACAM5 as a dynamic adverse prognostic CTC biomarker in patients with metastatic CRC and MSI-High is considered an unfavorable prognostic factor in metastatic CRC patient tumors. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer.
- Author
-
Michaelidou, Kleita, Koutoulaki, Chara, Mavridis, Konstantinos, Vorrias, Eleftherios, Papadaki, Maria A., Koutsopoulos, Anastasios V., Mavroudis, Dimitrios, and Agelaki, Sofia
- Subjects
- *
CELL-free DNA , *NON-small-cell lung carcinoma - Abstract
KRAS mutations are found in approximately one third of non-small cell lung cancer (NSCLC) patients. In this study, we aim to investigate whether KRAS G12/G13 mutant allele fraction (MAF) in cell-free DNA (cfDNA) can provide meaningful prognostic information in NSCLC. Multiplex droplet-digital PCR was used to quantitatively assess KRAS G12/G13 MAF in cfDNA from 114 pre-treated advanced disease NSCLC patients. In 14 patients, changes in KRAS G12/G13 MAF were longitudinally monitored during treatment. Plasma KRAS G12/G13 status was associated with poor patients' outcome in terms of progression-free survival (PFS) (p < 0.001) and overall survival (OS) (p < 0.001). In multivariate analysis, the detection of plasma KRAS mutations was an independent predictor of adverse PFS (HR = 3.12; p < 0.001) and OS (HR = 2.53; p = 0.002). KRAS G12/G13 MAF at first treatment evaluation (T1) was higher (p = 0.013) among patients experiencing progressive disease compared to those with disease control, and increased KRAS MAF at T1 was associated (p = 0.005) with shorter PFS. On the contrary, no association was observed between tissue KRAS mutation status and patients' prognosis. Our results show that ddPCR-based detection of KRAS G12/G13 mutations in plasma could serve as an independent biomarker of unfavorable prognosis in NSCLC patients. Changes in KRAS MAF can provide valuable information for monitoring patient outcome during treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.
- Author
-
Papadaki, Maria A., Koutsopoulos, Anastasios V., Tsoulfas, Panormitis G., Lagoudaki, Eleni, Aggouraki, Despoina, Monastirioti, Alexia, Koutoulaki, Chara, Apostolopoulou, Christina A., Merodoulaki, Aikaterini C., Papadaki, Chara, Mavroudis, Dimitrios, and Agelaki, Sofia
- Subjects
BREAST cancer prognosis ,ANTIGENS ,BODY fluid examination ,BREAST tumors ,CANCER relapse ,FLUORESCENT antibody technique ,GENE expression ,IMMUNOHISTOCHEMISTRY ,LYMPHOCYTES ,MEMBRANE proteins ,METASTASIS ,DISEASE progression ,DISEASE risk factors - Abstract
The role of CD47 and PD-L1 expression on circulating tumor cells (CTCs) remains unclear, and it is currently unknown whether their distribution varies between the blood and tumor tissue in breast cancer (BC). In this study, CD47 and PD-L1 expression was investigated a) on peripheral blood mononuclear cell (PBMC) cytospins from early (n = 100) and metastatic (n = 98) BC patients, by triple immunofluorescence for CD47/PD-L1/Cytokeratins, and b) on matched primary and/or metastatic tumor tissue from CTC-positive patients using immunohistochemistry. CD47+and/orPD-L1+ CTCs were detected in 11%, 16.9%, and 29.6% of early, recurrent, and de novo metastatic patients (p = 0.016). In metastatic disease, CD47
high and/orPD-L1high CTCs were associated with disease progression (p = 0.005) and shorter progression-free survival (PFS) (p = 0.010), and independently predicted for an increased risk of relapse (HR: 2.719; p = 0.008) and death (HR: 2.398; p = 0.034). PD-L1 expression rates differed between CTCs and tissue tumor cells and between peripheral blood mononuclear cells (PBMCs) and tumor-infiltrating lymphocytes (TILs) (positive concordance of 3.8% and 4%, respectively). CD47 expression also differed between CTCs and tumor cells (positive concordance of 11.5%). In conclusion, CTCs expressing CD47 and PD-L1 have independent poor prognostic implications in metastatic BC, indicating a potential role of innate and adaptive immune evasion mechanisms in their metastatic potential. The clinical value of the parallel assessment of the peripheral and local immune response merits further evaluation in BC. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
9. Aberrant expression of miR-21, miR-376c miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer.
- Author
-
Lasithiotaki, Ismini, Tsitoura, Eliza, Koutsopoulos, Anastasios, Lagoudaki, Eleni, Koutoulaki, Chara, Pitsidianakis, George, Spandidos, Demetrios A., Siafakas, Nikolaos M., Antoniou, Katerina M., and Sourvinos, George
- Subjects
- *
NON-small-cell lung carcinoma , *GENE expression , *MICRORNA , *MERKEL cell carcinoma , *POLYOMAVIRUSES - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.